CA2537880C - Composition for protecting proteins degradation comprising small heat shock proteins (shsps) and method of two-dimensional gel electrophoresis using the shsps - Google Patents
Composition for protecting proteins degradation comprising small heat shock proteins (shsps) and method of two-dimensional gel electrophoresis using the shsps Download PDFInfo
- Publication number
- CA2537880C CA2537880C CA2537880A CA2537880A CA2537880C CA 2537880 C CA2537880 C CA 2537880C CA 2537880 A CA2537880 A CA 2537880A CA 2537880 A CA2537880 A CA 2537880A CA 2537880 C CA2537880 C CA 2537880C
- Authority
- CA
- Canada
- Prior art keywords
- derived
- ibpa
- shsps
- protein
- ibpb
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 113
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 103
- 108091052270 small heat shock protein (HSP20) family Proteins 0.000 title claims abstract description 94
- 239000000203 mixture Substances 0.000 title claims abstract description 52
- 238000000539 two dimensional gel electrophoresis Methods 0.000 title claims abstract description 44
- 238000000034 method Methods 0.000 title claims abstract description 43
- 102000008063 Small Heat-Shock Proteins Human genes 0.000 title claims description 83
- 230000015556 catabolic process Effects 0.000 title claims description 11
- 238000006731 degradation reaction Methods 0.000 title claims description 11
- 230000017854 proteolysis Effects 0.000 claims abstract description 21
- 102000042290 small heat shock protein (HSP20) family Human genes 0.000 claims abstract 56
- 241000588724 Escherichia coli Species 0.000 claims description 37
- 241000282414 Homo sapiens Species 0.000 claims description 25
- 239000000499 gel Substances 0.000 claims description 24
- 238000001502 gel electrophoresis Methods 0.000 claims description 24
- 102000002812 Heat-Shock Proteins Human genes 0.000 claims description 20
- 108010004889 Heat-Shock Proteins Proteins 0.000 claims description 20
- 210000003000 inclusion body Anatomy 0.000 claims description 20
- 108091005804 Peptidases Proteins 0.000 claims description 18
- 239000004365 Protease Substances 0.000 claims description 18
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 18
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 18
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 18
- 210000004027 cell Anatomy 0.000 claims description 18
- 235000010582 Pisum sativum Nutrition 0.000 claims description 15
- 241000320117 Pseudomonas putida KT2440 Species 0.000 claims description 15
- 239000013612 plasmid Substances 0.000 claims description 15
- 241000607479 Yersinia pestis Species 0.000 claims description 13
- 241001138501 Salmonella enterica Species 0.000 claims description 10
- 241000219195 Arabidopsis thaliana Species 0.000 claims description 8
- 241001529936 Murinae Species 0.000 claims description 8
- 240000004713 Pisum sativum Species 0.000 claims description 8
- 108010026552 Proteome Proteins 0.000 claims description 8
- 241000589516 Pseudomonas Species 0.000 claims description 8
- 241000589196 Sinorhizobium meliloti Species 0.000 claims description 8
- 241001453191 Thermosynechococcus vulcanus Species 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 7
- 241000206602 Eukaryota Species 0.000 claims description 7
- 238000001962 electrophoresis Methods 0.000 claims description 6
- 241000710177 Citrus tristeza virus Species 0.000 claims description 5
- 102100039165 Heat shock protein beta-1 Human genes 0.000 claims description 4
- 101001036709 Homo sapiens Heat shock protein beta-1 Proteins 0.000 claims description 4
- 238000004458 analytical method Methods 0.000 claims description 4
- 244000005700 microbiome Species 0.000 claims description 4
- 241000589774 Pseudomonas sp. Species 0.000 claims description 3
- 241001196938 Brucella suis 1330 Species 0.000 claims description 2
- 241001522750 Escherichia coli CFT073 Species 0.000 claims description 2
- 241001646716 Escherichia coli K-12 Species 0.000 claims description 2
- 241001646719 Escherichia coli O157:H7 Species 0.000 claims description 2
- 241000010756 Escherichia coli O157:H7 str. EDL933 Species 0.000 claims description 2
- 241001240958 Pseudomonas aeruginosa PAO1 Species 0.000 claims description 2
- 241001538194 Shewanella oneidensis MR-1 Species 0.000 claims description 2
- 241000105479 Sinorhizobium meliloti 1021 Species 0.000 claims description 2
- 108010088928 Small Heat-Shock Proteins Proteins 0.000 claims 45
- 101000961320 Escherichia coli (strain K12) Protein YjaZ Proteins 0.000 claims 12
- 101100178679 Caenorhabditis elegans hsp-1 gene Proteins 0.000 claims 9
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 claims 9
- 241000607762 Shigella flexneri Species 0.000 claims 9
- 108010042653 IgA receptor Proteins 0.000 claims 8
- 241000219843 Pisum Species 0.000 claims 8
- 102100034014 Prolyl 3-hydroxylase 3 Human genes 0.000 claims 8
- 241000253994 Acyrthosiphon pisum Species 0.000 claims 7
- 241000253373 Caldanaerobacter subterraneus subsp. tengcongensis Species 0.000 claims 7
- 241000187479 Mycobacterium tuberculosis Species 0.000 claims 7
- 241000589954 Pirellula sp. Species 0.000 claims 7
- 241000205091 Sulfolobus solfataricus Species 0.000 claims 7
- 241000204673 Thermoplasma acidophilum Species 0.000 claims 7
- 241000589155 Agrobacterium tumefaciens Species 0.000 claims 6
- 241001148111 Brucella suis Species 0.000 claims 6
- 101710113881 Heat shock protein 26 Proteins 0.000 claims 6
- 241000590002 Helicobacter pylori Species 0.000 claims 6
- 241000204641 Methanopyrus kandleri Species 0.000 claims 6
- 241000186362 Mycobacterium leprae Species 0.000 claims 6
- 241000223960 Plasmodium falciparum Species 0.000 claims 6
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims 6
- 241000589776 Pseudomonas putida Species 0.000 claims 6
- 241001223867 Shewanella oneidensis Species 0.000 claims 6
- 241000187432 Streptomyces coelicolor Species 0.000 claims 6
- 229940037467 helicobacter pylori Drugs 0.000 claims 6
- 241000894010 Buchnera aphidicola Species 0.000 claims 5
- 241000203407 Methanocaldococcus jannaschii Species 0.000 claims 4
- 241000193996 Streptococcus pyogenes Species 0.000 claims 4
- 241001544493 Buchnera aphidicola str. APS (Acyrthosiphon pisum) Species 0.000 claims 3
- 101100071585 Caenorhabditis elegans hsp-16.2 gene Proteins 0.000 claims 3
- 101100339887 Drosophila melanogaster Hsp27 gene Proteins 0.000 claims 3
- 101150096895 HSPB1 gene Proteins 0.000 claims 3
- 241000203353 Methanococcus Species 0.000 claims 3
- 101150004229 NR0B2 gene Proteins 0.000 claims 3
- 241000700605 Viruses Species 0.000 claims 3
- 101150096065 shp gene Proteins 0.000 claims 3
- 241000751199 Agrobacterium fabrum str. C58 Species 0.000 claims 1
- 241001674329 Helicobacter pylori 26695 Species 0.000 claims 1
- 241000432069 Mycobacterium leprae TN Species 0.000 claims 1
- 241001505483 Plasmodium falciparum 3D7 Species 0.000 claims 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 claims 1
- 241000405383 Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 Species 0.000 claims 1
- 241001518902 Shigella flexneri 2a str. 2457T Species 0.000 claims 1
- 241001518905 Shigella flexneri 2a str. 301 Species 0.000 claims 1
- 241001446311 Streptomyces coelicolor A3(2) Species 0.000 claims 1
- 241001584856 Yersinia pestis CO92 Species 0.000 claims 1
- 241001117074 Yersinia pestis KIM10+ Species 0.000 claims 1
- 229940098714 salmonella enterica subsp. enterica serovar typhi Drugs 0.000 claims 1
- 230000002265 prevention Effects 0.000 abstract description 4
- 230000003247 decreasing effect Effects 0.000 abstract description 2
- 101150050258 Hsp26 gene Proteins 0.000 description 21
- 239000000243 solution Substances 0.000 description 20
- 241001302584 Escherichia coli str. K-12 substr. W3110 Species 0.000 description 18
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 210000002966 serum Anatomy 0.000 description 8
- 239000004202 carbamide Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000013611 chromosomal DNA Substances 0.000 description 6
- 238000001155 isoelectric focusing Methods 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
- 239000007983 Tris buffer Substances 0.000 description 5
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 5
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 5
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 238000003752 polymerase chain reaction Methods 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 235000019419 proteases Nutrition 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 2
- 241001453698 Buchnera <proteobacteria> Species 0.000 description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 2
- RDFCSSHDJSZMTQ-ZDUSSCGKSA-N Tos-Lys-CH2Cl Chemical compound CC1=CC=C(S(=O)(=O)N[C@@H](CCCCN)C(=O)CCl)C=C1 RDFCSSHDJSZMTQ-ZDUSSCGKSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- BKHZIBWEHPHYAI-UHFFFAOYSA-N chloroform;3-methylbutan-1-ol Chemical compound ClC(Cl)Cl.CC(C)CCO BKHZIBWEHPHYAI-UHFFFAOYSA-N 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 101150077063 ibpB gene Proteins 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000001742 protein purification Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- TWADEBCIPVNACR-ZDUSSCGKSA-N (2s)-2-(n-(4-methylphenyl)sulfonylanilino)propanoic acid Chemical compound C=1C=C(C)C=CC=1S(=O)(=O)N([C@@H](C)C(O)=O)C1=CC=CC=C1 TWADEBCIPVNACR-ZDUSSCGKSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- VPWNQTHUCYMVMZ-UHFFFAOYSA-N 4,4'-sulfonyldiphenol Chemical compound C1=CC(O)=CC=C1S(=O)(=O)C1=CC=C(O)C=C1 VPWNQTHUCYMVMZ-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 208000002109 Argyria Diseases 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241000237537 Ensis Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 241000589989 Helicobacter Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108700028337 Methanococcus jannaschii HSP16.5 Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- MQUQNUAYKLCRME-INIZCTEOSA-N N-tosyl-L-phenylalanyl chloromethyl ketone Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N[C@H](C(=O)CCl)CC1=CC=CC=C1 MQUQNUAYKLCRME-INIZCTEOSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000589956 Pirellula Species 0.000 description 1
- 241000224016 Plasmodium Species 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 241000697144 Syma Species 0.000 description 1
- 241000186339 Thermoanaerobacter Species 0.000 description 1
- 241000204667 Thermoplasma Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 241000607734 Yersinia <bacteria> Species 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- PXXJHWLDUBFPOL-UHFFFAOYSA-N benzamidine Chemical compound NC(=N)C1=CC=CC=C1 PXXJHWLDUBFPOL-UHFFFAOYSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000008004 cell lysis buffer Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940096118 ella Drugs 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000010429 evolutionary process Effects 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 101150022325 ibpA gene Proteins 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 1
- -1 isopropyl- Chemical group 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000000575 proteomic method Methods 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229940034880 tencon Drugs 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- OOLLAFOLCSJHRE-ZHAKMVSLSA-N ulipristal acetate Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(OC(C)=O)C(C)=O)[C@]2(C)C1 OOLLAFOLCSJHRE-ZHAKMVSLSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2003-0062756A KR100516389B1 (ko) | 2003-09-08 | 2003-09-08 | 작은 열 충격 단백질을 함유하는 단백질 분해 방지용조성물 및 이를 이용한 이차원 전기영동법 |
| KR10-2003-0062756 | 2003-09-08 | ||
| PCT/KR2003/002539 WO2005023847A1 (en) | 2003-09-08 | 2003-11-24 | COMPOSITION FOR PROTECTING PROTEINS DEGRADATION COMPRISING SMALL HEAT SHOCK PROTEINS (sHSPs) AND METHOD OF TWO-DIMENSIONAL GEL ELECTROPHORESIS USING THE sHSPs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2537880A1 CA2537880A1 (en) | 2005-03-17 |
| CA2537880C true CA2537880C (en) | 2011-11-01 |
Family
ID=36241956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2537880A Expired - Lifetime CA2537880C (en) | 2003-09-08 | 2003-11-24 | Composition for protecting proteins degradation comprising small heat shock proteins (shsps) and method of two-dimensional gel electrophoresis using the shsps |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7148334B2 (OSRAM) |
| EP (1) | EP1664094B1 (OSRAM) |
| JP (1) | JP4268556B2 (OSRAM) |
| KR (1) | KR100516389B1 (OSRAM) |
| CN (1) | CN1839151B (OSRAM) |
| AT (1) | ATE414101T1 (OSRAM) |
| AU (1) | AU2003284750B2 (OSRAM) |
| CA (1) | CA2537880C (OSRAM) |
| DE (1) | DE60324712D1 (OSRAM) |
| WO (1) | WO2005023847A1 (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005332120B2 (en) * | 2005-05-23 | 2010-08-26 | Korea Advanced Institute Of Science And Technology | Method for preparing a target protein using the sHSPs |
| CN121160589A (zh) * | 2025-11-21 | 2025-12-19 | 齐鲁工业大学(山东省科学院) | 一种无抗生素标签诱导型耐盐类球红细菌工程菌及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4239969A1 (de) * | 1992-11-27 | 1994-06-01 | Boehringer Mannheim Gmbh | Verfahren zur Stabilisierung von Proteinen |
| US5837251A (en) * | 1995-09-13 | 1998-11-17 | Fordham University | Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases |
| US5993627A (en) * | 1997-06-24 | 1999-11-30 | Large Scale Biology Corporation | Automated system for two-dimensional electrophoresis |
| US6554991B1 (en) * | 1997-06-24 | 2003-04-29 | Large Scale Proteomics Corporation | Automated system for two-dimensional electrophoresis |
| AU2001236726A1 (en) * | 2000-02-08 | 2001-08-20 | The Regents Of The University Of Michigan | Protein separation and display |
| CA2409347C (en) * | 2000-04-14 | 2010-03-30 | Frank T. Robb | Enhanced protein thermostability and temperature resistance |
| WO2002090966A1 (en) | 2001-05-10 | 2002-11-14 | Large Scale Proteomics Corporation | Automated apparatus for separating a biological sample from a two dimensional electrophoresis gel |
| US20050064545A1 (en) * | 2002-01-07 | 2005-03-24 | Demarco Ario | Recombinant protein expression |
-
2003
- 2003-09-08 KR KR10-2003-0062756A patent/KR100516389B1/ko not_active Expired - Fee Related
- 2003-11-24 DE DE60324712T patent/DE60324712D1/de not_active Expired - Lifetime
- 2003-11-24 WO PCT/KR2003/002539 patent/WO2005023847A1/en not_active Ceased
- 2003-11-24 AT AT03774298T patent/ATE414101T1/de not_active IP Right Cessation
- 2003-11-24 EP EP03774298A patent/EP1664094B1/en not_active Expired - Lifetime
- 2003-11-24 CN CN2003801104474A patent/CN1839151B/zh not_active Expired - Fee Related
- 2003-11-24 CA CA2537880A patent/CA2537880C/en not_active Expired - Lifetime
- 2003-11-24 AU AU2003284750A patent/AU2003284750B2/en not_active Ceased
-
2004
- 2004-03-02 US US10/791,059 patent/US7148334B2/en not_active Expired - Fee Related
- 2004-03-31 JP JP2004108476A patent/JP4268556B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1664094A1 (en) | 2006-06-07 |
| CN1839151A (zh) | 2006-09-27 |
| EP1664094A4 (en) | 2006-09-27 |
| US7148334B2 (en) | 2006-12-12 |
| DE60324712D1 (de) | 2008-12-24 |
| CN1839151B (zh) | 2011-02-09 |
| ATE414101T1 (de) | 2008-11-15 |
| CA2537880A1 (en) | 2005-03-17 |
| AU2003284750B2 (en) | 2009-09-10 |
| US20050123994A1 (en) | 2005-06-09 |
| JP2005084048A (ja) | 2005-03-31 |
| KR100516389B1 (ko) | 2005-09-23 |
| KR20050025819A (ko) | 2005-03-14 |
| EP1664094B1 (en) | 2008-11-12 |
| WO2005023847A1 (en) | 2005-03-17 |
| JP4268556B2 (ja) | 2009-05-27 |
| AU2003284750A1 (en) | 2005-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Margolin et al. | Cloning and characterization of a Rhizobium meliloti homolog of the Escherichia coli cell division gene ftsZ | |
| US20060248617A1 (en) | Method of targeted gene disruption, genome of hyperthermostable bacterium and genome chip using the same | |
| Phadke et al. | Analysis of the outer membrane proteome of Caulobacter crescentus by two‐dimensional electrophoresis and mass spectrometry | |
| US8535909B2 (en) | E. coli BL21 strain lacking a functional group II capsular gene cluster | |
| JP3998155B2 (ja) | 空胞形成毒素欠損Ｈ．ｐｙｌｏｒｉおよび関連する方法 | |
| CA2537880C (en) | Composition for protecting proteins degradation comprising small heat shock proteins (shsps) and method of two-dimensional gel electrophoresis using the shsps | |
| CN116635401A (zh) | 具有改进性能的基因修饰的甲基菌 | |
| CN113373171A (zh) | 一种在大肠杆菌内稳定遗传的酵母-大肠杆菌穿梭质粒及其构建方法 | |
| JP7230130B2 (ja) | マイコプラズマ・ヒオリニス感染を予防治療する組成物及びその活性成分を生産するための発現ベクター及び方法 | |
| Eggenhofer et al. | MotD of Sinorhizobium meliloti and related α-proteobacteria is the flagellar-hook-length regulator and therefore reassigned as FliK | |
| Takata et al. | The purification of a GroEL‐like stress protein from aerobically adapted Campylobacter jejuni | |
| CN112979769A (zh) | 一种氨基酸序列、蛋白质及其制备方法和应用 | |
| KR100860932B1 (ko) | 신규한 프로모터 및 이의 용도 | |
| AU2003247177A1 (en) | Method for producing target proteins by deleting or amplifying ibpA and/or ibpB gene coding for inclusion body-associated proteins | |
| Ursin et al. | Cloning and nucleotide sequence of a tobacco chloroplast translational elongation factor, EF-Tu | |
| CN115109784A (zh) | 一种向日葵品种龙食葵叶绿体基因组及其应用 | |
| CN114214351A (zh) | 一种志贺氏菌多糖表达质粒及其用途 | |
| Clark et al. | News & Notes: Buchnera aphidicola (Aphid Endosymbiont) Contains Genes Encoding Enzymes of Histidine Biosynthesis | |
| Yamamoto et al. | Cloning and nucleotide sequence analysis of immunodominant heat-shock protein of Yersinia enterocolitica | |
| CN117264859B (zh) | 一种原核表达系统及其制备方法和应用 | |
| KR100655493B1 (ko) | 작은 열 충격 단백질을 이용한 목적단백질의 제조방법 | |
| US8067552B2 (en) | Method for preparing a target protein using the sHSPs | |
| KR100829727B1 (ko) | 재조합 단백질 또는 펩타이드의 용해도를 증가시키는 방법 | |
| CN114460303A (zh) | 一种猪囊等孢球虫CsENO2蛋白与宿主细胞未知蛋白互作的方法 | |
| Fujii-Muramatsu et al. | Biochemical Society. All rights reserved. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |